Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Ureteral Neoplasms × Electroporation × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 6 Carcinoma, Hepatocellular 5 Pancreatic Neoplasms 4 Liver Neoplasms 4 Lymphatic Metastasis 2 Locally Advanced Pancreatic Cancer 2 Cholangiocarcinoma 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Ureteral Neoplasms 1 Unresectable Pancreatic Cancer 1 Stomach Neoplasms 1 Rectal Neoplasms 1 Pancreatic Ductal Adenocarcinoma 1 Pancreatic Adenocarcinoma Resectable 1 Neoplasms 1 Neoplasm Metastasis 1 Lung Neoplasms 1 Liver Diseases 1 Laryngeal Neoplasms 1 Head and Neck Neoplasms 1 Gallbladder Neoplasms 1 Extremities Neoplasms 1 Esophageal Neoplasms 1 Carcinoma, Renal Cell 1 Bile Duct Neoplasms 1

Interventions

Radiotherapy 1 Nephroureterectomy 1 Methods 1 Lymph Node Excision 1 Electroporation 1 Early Intervention, Educational 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02430779 2021-09-05

IRE

Fuda Cancer Hospital, Guangzhou

Phase NA Completed

Ureteral Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡